Juvenile myelomonocytic leukemia epidemiology and demographics: Difference between revisions
No edit summary |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 10: | Line 10: | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 16:39, 9 August 2012
|
Juvenile myelomonocytic leukemia Microchapters |
|
Differentiating Juvenile myelomonocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Juvenile myelomonocytic leukemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia epidemiology and demographics |
|
FDA on Juvenile myelomonocytic leukemia epidemiology and demographics |
|
CDC on Juvenile myelomonocytic leukemia epidemiology and demographics |
|
Juvenile myelomonocytic leukemia epidemiology and demographics in the news |
|
Blogs on Juvenile myelomonocytic leukemia epidemiology and demographics |
|
Risk calculators and risk factors for Juvenile myelomonocytic leukemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
JMML accounts for 1-2% of childhood leukemias each year; in the United States, an estimated 25-50 new cases are diagnosed each year, which also equates to about 3 cases per million children. There is no known environmental cause for JMML. Since about 10% of patients are diagnosed before 3 months of age, it is thought that JMML is a congenital condition in these infants.